Jeune Aesthetics, a wholly owned subsidiary of Krystal Biotech (KRYS), announced the appointment of Marc Forth as Chief Executive Officer effective today. A veteran of the healthcare industry, Mr. Forth has over 30 years of commercial and executive leadership experience, with an extensive track record of building innovative companies as well as launching and commercializing leading brands, including BOTOX(R), one of the most widely recognized global brands. Mr. Forth has also served as a valuable contributor on Jeune’s board of directors since February 2021.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRYS:
- Palvella Therapeutics initiated with an Outperform at Scotiabank
- Royal Caribbean upgraded, AppLovin downgraded: Wall Street’s top analyst calls
- Krystal Biotech initiated with a Buy at Jefferies
- Krystal Biotech’s Growth Potential: Strong Vyjuvek Launch and Promising Pipeline
- Krystal Biotech’s Vyjuvek: Anticipated European Approval and Strong Sales Projections Drive Buy Rating